Literature DB >> 12607231

The genetic heterogeneity of "schizophrenia".

H Beckmann1, E Franzek.   

Abstract

The main reason for the inconsistent findings in schizophrenia research is the lack of diagnostic conformity. This has not changed markedly following the introduction of modern operational diagnostic systems. Taking schizophrenia as a disease entity or assuming schizophrenia spectrum psychoses to represent a continuum of diseases without any clear dividing lines, the results of family and twin studies point to a multifactorial etiology based on a polygenic mode of transmission. Further, then it has to be assumed a familial continuum from schizophrenia to affective psychosis and other spectrum disorders. However, in family and twin studies based on Leonhard's classification, there is clearcut evidence that schizophrenic spectrum psychoses have to be divided into clinical and etiological subgroups with a completely different genetic background. For example, systematic catatonia is, for the most part, a sporadic disease, whereas periodic catatonia aggregates in families in a manner consistent with a major gene effect. Further, the results indicate that schizophrenic spectrum psychoses consist of three main valid categories: cycloid psychoses, unsystematic schizophrenias and systematic schizophrenias. In the case of cycloid psychosis and systematic schizophrenias, genetic loading seem to be very low, while "environmental" factors, for example, birth complications, may play an important etiological role. Unsystematic schizophrenias, however, are predominantly inherited and "environmental" factors are not very prominent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12607231     DOI: 10.3109/15622970009150564

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  8 in total

1.  Protein-protein interaction and pathway analyses of top schizophrenia genes reveal schizophrenia susceptibility genes converge on common molecular networks and enrichment of nucleosome (chromatin) assembly genes in schizophrenia susceptibility loci.

Authors:  Xiongjian Luo; Liang Huang; Peilin Jia; Ming Li; Bing Su; Zhongming Zhao; Lin Gan
Journal:  Schizophr Bull       Date:  2013-05-12       Impact factor: 9.306

2.  Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case-control study.

Authors:  For-Wey Lung; Bih-Ching Shu; Wei-Tsung Kao; C Nathan Chen; Yu-Chi Ku; Dong-Sheng Tzeng
Journal:  BMC Med Genet       Date:  2009-12-29       Impact factor: 2.103

3.  The role of Pannexin gene variants in schizophrenia: systematic analysis of phenotypes.

Authors:  Micha Gawlik; Martin Wagner; Bruno Pfuhlmann; Gerald Stöber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-07-30       Impact factor: 5.270

Review 4.  Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia?

Authors:  S Bender; M Weisbrod; F Resch
Journal:  J Neural Transm (Vienna)       Date:  2007-05-21       Impact factor: 3.575

5.  Advanced paternal age is a risk factor for schizophrenia in Iranians.

Authors:  Morteza Naserbakht; Hamid-Reza Ahmadkhaniha; Bahareh Mokri; Cassandra L Smith
Journal:  Ann Gen Psychiatry       Date:  2011-04-24       Impact factor: 3.455

6.  DNA methylation studies using twins: what are they telling us?

Authors:  Jordana T Bell; Tim D Spector
Journal:  Genome Biol       Date:  2012-10-18       Impact factor: 13.583

7.  Generalised Anxiety Disorder--A Twin Study of Genetic Architecture, Genome-Wide Association and Differential Gene Expression.

Authors:  Matthew N Davies; Serena Verdi; Andrea Burri; Maciej Trzaskowski; Minyoung Lee; John M Hettema; Rick Jansen; Dorret I Boomsma; Tim D Spector
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

Review 8.  Epigenetics of discordant monozygotic twins: implications for disease.

Authors:  Juan E Castillo-Fernandez; Tim D Spector; Jordana T Bell
Journal:  Genome Med       Date:  2014-07-31       Impact factor: 11.117

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.